(R)-4-(tert-Butyl)-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 97%, 250mg

N,N,2-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 500mg

4-(5-Methoxy-2-trifluoromethyl-phenyl)-pyridine-2-carbonitrile, 95.0%, 1g

8-Bromo-2-methylisoquinolin-1(2H)-one, 95.0%, 5g

1-(Isocyano(tosyl)methyl)-3-(trifluoromethyl)benzene, 95.0%, 250mg

[1,1'-Biphenyl]-4-acetic acid, 4'-[3-methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl]-, 10mg

3,5-Dimethoxyphenylacetonitrile, 96.0%, 5g

3-Pentadecylphenol>90.0%(GC)25g

5-Iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole, 95.0%, 5g

(1R,2S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid, 95%, 100mg

(E)-3-(3-Bromo-4-hydroxy-5-methoxyphenyl)acrylic acid, 98%, 5g

Methyl 2-(2,5-dioxoimidazolidin-4-yl)acetate, 95.0%, 100mg

Dimethyl (diazomethyl)phosphonate, 95.0%, 250mg